lumbar neuralgia
Conditions
Interventions
Control group:Ultrasound guidance + short-axis laminectomy
Test group:Ultrasound guidance + long axis articular process and transverse process section
Sponsors
Affiliated Hospital of Jiangsu University
Eligibility
Sex/Gender
All
Age
18 Years to 95 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 95 years old, regardless of gender, clinically diagnosed as lumbar neuralgia (duration >= 1 month), such as herpes zoster neuralgia extending to the waist, or MRI/CT confirmed lumbar disc herniation, lumbar spinal stenosis and other lesions that cause lumbar nerve root compression or inflammation; 2. Pain is mainly manifested as radiating pain in the waist, hips and lower limbs, with a visual analogue scale (VAS) >= 4 points, and conservative treatment (such as drugs, physical therapy) for more than 2 weeks is ineffective; 3. The segment of lumbar neuropathy is clear; 4. The patient can clearly describe the hitting/twitching/beating sensation in the buttocks or lower limbs caused by radiofrequency stimulation, and can cooperate to complete intraoperative positioning verification and postoperative follow-up; 5. American Society of Anesthesiologists (ASA) classification I to III, without severe cardiopulmonary dysfunction, and able to tolerate operations in the prone or lateral position.
Exclusion criteria
Exclusion criteria: 1. The skin at the puncture site is infected, ulcerated, or combined with systemic infection; 2. Abnormal coagulation function (such as significantly prolonged prothrombin time, platelet count <80×10^9/L); 3. Severe cauda equina compression, symptoms of spinal cord degeneration, and severe numbness due to nerve root compression; 4. severe spinal deformity affects ultrasound anatomical structure identification; 5. Those with mental disorders (such as depression, cognitive impairment) or long-term use of psychotropic drugs cannot cooperate with intraoperative stimulation response judgment and postoperative pain assessment; 6. Allergy to treatment-related drugs; 7. The combined functions of important organs such as the heart, lungs, liver, and kidneys are severely damaged, and the patient cannot tolerate minimally invasive interventional treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of punctures;Target hit rate;Positioning time;VAS score ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions;Ultrasound image quality score;patient satisfaction score; | — |
Countries
China
Contacts
Public ContactLi Chunye
Affiliated Hospital of Jiangsu University
Outcome results
None listed